Bill Haynes is Corporate Vice President of the Novo Nordisk Research Centre Oxford and Visiting Professor in Metabolic Medicine at the University of Oxford.
Bill has been a member of REACT's Independent Strategic Advisory Board since 2026.
Bill Haynes is Corporate Vice President of the Novo Nordisk Research Centre Oxford and Visiting Professor in Metabolic Medicine at the University of Oxford.
Bill has been a member of REACT's Independent Strategic Advisory Board since 2026.